For more detailed information on the actions, administration and possible side effects for each of the following medications, please consult the Package Insert, available on-line and at pharmacies.

The information provided here regarding particular medications is intended solely for general information and should NOT be relied upon for any particular diagnosis, treatment, or care. Inclusion in this list does not imply an endorsement by NOF or Dr Stone of any particular medication or manufacturer.

For more detailed information on the actions, administration and possible side effects for each of the following medications, please consult the Package Insert, available on-line and at pharmacies.

Parathyroid Hormone
(Brand name Fortéo®)

Teriparatide, a form of parathyroid hormone, is approved for the treatment of osteoporosis in postmenopausal women and men who are at high risk for a fracture. This medication stimulates new bone formation and significantly increases bone mineral density. In postmenopausal women, fracture reduction was noted in the spine, hip, foot, ribs and wrist. In men, fracture reduction was noted in the spine, but there were insufficient data to evaluate fracture reduction at other sites. Teriparatide is self-administered as a daily injection for up to 24 months.

Side effects include nausea, leg cramps and dizziness.

Information on this page was obtained from the National Osteoporosis Foundation website, www.nof.org.